Get the Stockscreener App
0.00
100.00%
-5.8435
Fsd Pharma Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
See More
Previous Close:
$5.8435
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$63,710
Revenue:
-
Net Income/Loss:
$-17.90M
P/E Ratio:
0.00
EPS:
-0.75
Net Cash Flow:
$-10.83M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$97.50
Fsd Pharma Inc Stock (HUGE) Company Profile
Fsd Pharma Inc Stock (HUGE) Latest News
InvestmentPitch Media Video Discusses FSD Pharma's New OTCQB Symbol and Appointment of Former U.S. Congressman Stephen Buyer to its Board of DirectorsVideo Available on Investmentpitch.com - Marketscreener.com
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH - Marketscreener.com
Quantum BioPharma sues over alleged stock spoofing - The Globe and Mail
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update - AccessWire
InvestmentPitch Media Video Discusses FSD Pharma and Construction of its Heritage Museum and Flagship Dispensary at the Former Kraft Plant in OntarioVideo Available on Investmentpitch.com - Marketscreener.com
Quantum BioPharma (NASDAQ:QNTM) Stock Quotes, Forecast and News Summary - Benzinga
FSD Pharma Completes Name Change to Quantum BioPharma and 65:1 ConsolidationTrading Under New Ticker Symbol "QNTM" - StockTitan
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024 - MSN
FSD Pharma Rebrands As Quantum BioPharma: Major Share Consolidation Announced - Benzinga
FSD Pharma changes its name to Quantum BioPharma - Green Market Report
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace
CSE:HUGE Forum Post | opsd1-36173019 | This is Going to Change Society | FSD Pharma Inc - Stockhouse Publishing
HUGEFSD Pharma Inc. Latest Stock News & Market Updates - StockTitan
FSD Pharma Rebrands and Consolidates Shares - TipRanks
FSD Pharma Announces Share Consolidation and Name Change - StockTitan
FSD Pharma Inc expected to post a loss of 6 cents a shareEarnings Preview - XM
Huge Gains, Huge Volume for Biopharma Stock FSD Pharma Inc (NASDAQ: HUGE) (CSE: HUGE) - Investorideas.com newswire
Why FSD Pharma Stock Is Seeing Huge Gains - Benzinga
FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock? - InvestorPlace
FSD Pharma Backs Celly Nutrition’s Innovative Recovery Drink Launch - TipRanks
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this MonthCreated by a World-Class Pharmaceutical Research & Development Team - Milton Daily Standard
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - InvestorPlace
Celly Nutrition Corp.: Celly Nutrition Secures Additional Financing to Launch unbuzzd Stick Packs this MonthCreated by a World-Class Pharmaceutical Research & Development Team - finanznachrichten.de
FSD Pharma stock plunges to 52-week low of $0.07 By Investing.com - Investing.com Canada
FSD Pharma stock plunges to 52-week low of $0.07 - Investing.com
FSD Pharma Inc (HUGE) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Company’s Banking Shares: Up -95.15% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle
60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split - Yahoo Finance
Investor’s Toolkit: Key Ratios for Assessing FSD Pharma Inc (HUGE)’s Performance - The Dwinnex
FSD Pharma Inc [HUGE] Is Currently -7.92 below its 200 Period Moving Avg: What Does This Mean? - The DBT News
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Top investors say FSD Pharma Inc (HUGE) ticks everything they need - SETE News
FSD Pharma Inc Inc. (HUGE) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
FSD Pharma stock plunges to 52-week low of $0.13 amid market challenges - Investing.com Canada
Trading Day Review: FSD Pharma Inc (HUGE) Loses Momentum, Closing at 0.15 - The Dwinnex
HUGE (FSD Pharma Inc) has impressive results - US Post News
KBW Insurance Index (KIX) QuotePress Release - The Globe and Mail
TSX Financials Capped Index (TTFS) QuotePress Release - The Globe and Mail
S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail
S&P 500 Consumer Discretionary [Sector] (SRCD) QuotePress Release - The Globe and Mail
Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
24/7 Market News Publishes Report Covering Functional Beverage Market, Featuring FSD Pharma - Markets Insider
Rivian Automotive Inc Cl A (RIVN-Q) QuotePress Release - The Globe and Mail
Fsd Pharma Inc Cl B (HUGE-Q) QuotePress Release - The Globe and Mail
Union Pacific Corp (UNP-N) QuotePress Release - The Globe and Mail
Curaleaf Holdings Inc (CURA-T) QuotePress Release - The Globe and Mail
Gasoline RBOB (RBU23) Quote - The Globe and Mail
Fsd Pharma Inc Stock (HUGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
1.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):